84.76
price up icon0.69%   0.58
 
loading

Warum fällt Alcon Inc-Aktie (ALC)?

Wir haben während der Handelssitzung 2024-11-12 einen Rückgang der Aktie Alcon Inc (ALC) um 5.84% festgestellt. Obwohl dies auf normale Volatilität oder verschiedene interne und externe Faktoren zurückzuführen sein kann, beachten Sie bitte, dass wir die Situation aktiv beobachten und so schnell wie möglich zeitnahe Updates bereitstellen!
2023-11-15:

Shares of Alcon Inc. (ALC) dropped by 5.91% from $74.96 to $70.53 in the trading on Wednesday, Novemeber 15, 2023. The reason why ALC is down today is due to disappointing Q3 sales and a revised full-year forecast.

  • Q3 sales: In Q3 2023, Alcon reported core EPS of 66 cents, up 32% YoY (41% at CER), missing estimates by 1.5%. Diluted EPS was 41 cents, a 78% increase from the previous year. Q3 net sales reached $2.30 billion, missing estimates by 1.6%, with an 8.4% YoY increase (9% at CER). In segment performance, sales in surgical came at $1.28 billion, up 5% YoY (6% at CER), but below estimates; meanwhile, sales in vision care hit $1.00 billion, up 13% YoY, exceeding projections.
  • Full year outlook: Alcon provided an updated outlook for the full year 2023, anticipating net sales in the range of $9.3 billion to $9.4 billion (previously $9.3 billion to $9.5 billion). This revised range suggests a growth rate of 10-11% at CER compared to 2022, up from the earlier projected growth of 9-11%. The Zacks Consensus Estimate for ALC’s revenues is pegged at $9.48 billion.
medical_instruments_supplies RMD
$237.27
price up icon 2.46%
medical_instruments_supplies WST
$331.40
price up icon 1.34%
medical_instruments_supplies COO
$93.44
price up icon 1.64%
medical_instruments_supplies BDX
$227.68
price up icon 1.72%
$71.65
price up icon 1.26%
Kapitalisierung:     |  Volumen (24h):